Article
Interleukin-32θ Triggers Cellular Senescence and Reduces Sensitivity to Doxorubicin-Mediated Cytotoxicity in MDA-MB-231 Cells.
International journal of molecular sciences - 7 May 2021
Pham Thu-Huyen, Park Hyo-Min, Kim Jinju, Hong Jin-Tae, Yoon Do-Young
Abstract excerpt
The recently discovered interleukin (IL)- 32 isoform IL-32θ exerts anti-metastatic effects in the breast tumor microenvironment. However, the involvement of IL-32θ in breast cancer cell proliferation is not yet fully understood; therefore, the current study aimed to determine how IL-32θ affects cancer cell growth and evaluated the responses of IL-32θ-expressing cells to other cancer therapy. We compared the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
